Long-term oral anticoagulant therapy: Update on indications, therapeutic ranges, and monitoring

G. Raj, R. Kumar, W. P. McKinney

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


Oral anticoagulant therapy is used extensively in the treatment of deep venous thrombosis-pulmonary embolism and prevention of systemic thromboembolism. Adoption of the International Normalized Ratio system for the laboratory monitoring of therapy has solved the problems encountered with the variable sensitivities of the available thromboplastins in North America. Although in recent years the recommended intensity of treatment has been reduced for many indications, bleeding remains the most common side effect of long-term oral anticoagulation therapy. Several drugs interact with warfarin sodium, the most commonly used oral anticoagulant drug, and potentiate its effect, thereby increasing the risk of bleeding. However, awareness of potential drug interactions and careful monitoring to maintain patients within the recommended therapeutic ranges can minimize the risk of bleeding and lead to its safe use in most patients.

Original languageEnglish (US)
Pages (from-to)128-132
Number of pages5
JournalAmerican Journal of the Medical Sciences
Issue number2
StatePublished - 1994

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Long-term oral anticoagulant therapy: Update on indications, therapeutic ranges, and monitoring'. Together they form a unique fingerprint.

Cite this